Clinical Trial Update: Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program

View source ↗

Summary

This clinical trial update reports the completion of a national telemonitoring program evaluating the use of SGLT2 inhibitors in heart failure patients, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Mildly Reduced Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Satelia | Conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF) | Status: COMPLETED